M. Itzhaki

Long-term survival of patients with unresectable colorectal cancer liver metastases following infusional chemotherapy with 5-fluorouracil, leucovorin, oxaliplatin and surgery

Sylvie Giacchetti, M. Itzhaki, G. Gruia et al. · Annals of Oncology · 1999 · 607 citations

Medicine, Oncology, Surgery +16

Two consecutive phase II studies of oxaliplatin (L-OHP) for treatment of patients with advanced colorectal carcinoma who were resistant to previous treatment with fluoropyrimidines

D. Machover, Eduardo Díaz‐Rubio, Aimery de Gramont et al. · Annals of Oncology · 1996 · 434 citations · Full text

Medicine, Oncology, Pharmacotherapy +13

Chronomodulated Versus Fixed-Infusion—Rate Delivery of Ambulatory Chemotherapy With Oxaliplatin, Fluorouracil, and Folinic Acid (Leucovorin) in Patients With Colorectal Cancer Metastases: a Randomized Multi-institutional Trial

Françis Lévi, Rachid Zidani, Jean-Michel Vannetzel et al. · JNCI Journal of the National Cancer Institute · 1994 · 396 citations

Medicine, Oncology, Pharmacology +16

Phase I Trial of 5-Day Continuous Venous Infusion of Oxaliplatin at Circadian Rhythm-Modulated Rate Compared With Constant Rate

J. P. Caussanel, Francis Lévi, S. Brienza et al. · JNCI Journal of the National Cancer Institute · 1990 · 252 citations

Medicine, Oncology, Pharmacology +17

Oxaliplatin activity against metastatic colorectal cancer. A phase II study of 5-day continuous venous infusion at circadian rhythm modulated rate

Francis Lévi, B Perpoint, Carlo Garufi et al. · European Journal of Cancer · 1993 · 216 citations

Medicine, Oncology, Pharmacology +17